Baidu
map

Sci Rep:注意力缺陷多动症与过敏症状和低水平的血红蛋白和血清素相关

2018-07-24 AlexYang MedSci原创

最近,有研究人员调查了是否常见的并发症或者生化因子,比如过敏性疾病、贫血、炎症和神经传导物质,单独或者组合地与注意力缺陷多动症障碍(ADHD)风险的增加相关。研究募集了216名诊断为ADHD的儿童,包括了216名在年龄、性别、身高、体重和年纪匹配的对照,他们均来自台北市的小学。研究人员利用哮喘和过敏国际调查问卷的儿童调查问卷测量了过敏症状,搜集了空腹静脉血来分析全血细胞计数、白细胞分类计数、免疫球

最近,有研究人员调查了是否常见的并发症或者生化因子,比如过敏性疾病、贫血、炎症和神经传导物质,单独或者组合地与注意力缺陷多动症障碍(ADHD)风险的增加相关。

研究募集了216名诊断为ADHD的儿童,包括了216名在年龄、性别、身高、体重和年纪匹配的对照,他们均来自台北市的小学。研究人员利用哮喘和过敏国际调查问卷的儿童调查问卷测量了过敏症状,搜集了空腹静脉血来分析全血细胞计数、白细胞分类计数、免疫球蛋白(lg)E水平和血清素水平(5-HT)。研究发现,鼻炎(OR=2.08, 95% CI=1.42-3.05)和湿疹(OR=1.72, 95% CI=1.02-2.88)症状与ADHD风险的增加显著相关。与对照儿童相比,患有ADHD的儿童表现出了明显更低的血红蛋白(p=0.001)和5-HT(p<0.001),以及更高的lgE水平(p<0.001)和嗜酸粒细胞数(P=0.001)。另外,ADHD风险上述生化危险因素存在的存在而增加(1个因素: OR=1.87, 95% CI=0.87-4.18;2个因素: OR=2.90, 95% CI=1.29-6.48;3个因素: OR=4.47, 95% CI=1.97-10.13;4个因素: OR=6.53, 95% CI=2.43-17.57)。

最后,研究人员指出,他们的发现表明了ADHD的病因是多方面的,并且上述的因素也是ADHD的病因一部分。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2037491, encodeId=8345203e491be, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Nov 08 04:56:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348662, encodeId=a88a13486620f, content=<a href='/topic/show?id=bf444306e0f' target=_blank style='color:#2F92EE;'>#多动症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43067, encryptionId=bf444306e0f, topicName=多动症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515701, encodeId=a5211515e0181, content=<a href='/topic/show?id=cd636500e2e' target=_blank style='color:#2F92EE;'>#注意力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65007, encryptionId=cd636500e2e, topicName=注意力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=096e10855142, createdName=12498c24m72暂无昵称, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516455, encodeId=5cfc15164558c, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333900, encodeId=faf133390031, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:09:29 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2037491, encodeId=8345203e491be, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Nov 08 04:56:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348662, encodeId=a88a13486620f, content=<a href='/topic/show?id=bf444306e0f' target=_blank style='color:#2F92EE;'>#多动症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43067, encryptionId=bf444306e0f, topicName=多动症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515701, encodeId=a5211515e0181, content=<a href='/topic/show?id=cd636500e2e' target=_blank style='color:#2F92EE;'>#注意力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65007, encryptionId=cd636500e2e, topicName=注意力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=096e10855142, createdName=12498c24m72暂无昵称, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516455, encodeId=5cfc15164558c, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333900, encodeId=faf133390031, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:09:29 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
    2018-07-26 lq1767
  3. [GetPortalCommentsPageByObjectIdResponse(id=2037491, encodeId=8345203e491be, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Nov 08 04:56:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348662, encodeId=a88a13486620f, content=<a href='/topic/show?id=bf444306e0f' target=_blank style='color:#2F92EE;'>#多动症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43067, encryptionId=bf444306e0f, topicName=多动症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515701, encodeId=a5211515e0181, content=<a href='/topic/show?id=cd636500e2e' target=_blank style='color:#2F92EE;'>#注意力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65007, encryptionId=cd636500e2e, topicName=注意力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=096e10855142, createdName=12498c24m72暂无昵称, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516455, encodeId=5cfc15164558c, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333900, encodeId=faf133390031, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:09:29 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2037491, encodeId=8345203e491be, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Nov 08 04:56:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348662, encodeId=a88a13486620f, content=<a href='/topic/show?id=bf444306e0f' target=_blank style='color:#2F92EE;'>#多动症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43067, encryptionId=bf444306e0f, topicName=多动症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515701, encodeId=a5211515e0181, content=<a href='/topic/show?id=cd636500e2e' target=_blank style='color:#2F92EE;'>#注意力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65007, encryptionId=cd636500e2e, topicName=注意力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=096e10855142, createdName=12498c24m72暂无昵称, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516455, encodeId=5cfc15164558c, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333900, encodeId=faf133390031, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:09:29 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2037491, encodeId=8345203e491be, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Nov 08 04:56:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348662, encodeId=a88a13486620f, content=<a href='/topic/show?id=bf444306e0f' target=_blank style='color:#2F92EE;'>#多动症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43067, encryptionId=bf444306e0f, topicName=多动症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515701, encodeId=a5211515e0181, content=<a href='/topic/show?id=cd636500e2e' target=_blank style='color:#2F92EE;'>#注意力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65007, encryptionId=cd636500e2e, topicName=注意力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=096e10855142, createdName=12498c24m72暂无昵称, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516455, encodeId=5cfc15164558c, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Thu Jul 26 10:56:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333900, encodeId=faf133390031, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:09:29 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
    2018-07-24 1e0f8808m18(暂无匿称)

    学习了,谢谢分享。

    0

相关资讯

JAMA Psychiatry:多动症患者高考期间药别停 分数可能比不服药时高

注意缺陷/多动障碍(ADHD)是儿童期常见的一类心理障碍。表现为注意力不集中或注意时间短暂、活动过度和冲动,并且常伴有学习困难等问题。2017年8月,发表在《JAMA Psychiatry》的一项由澳大利亚、瑞典和美国进行的队列研究,考察了ADHD患者药物使用和表现与高考分数之间的相关性。

Pediatr Allergy Immunol:中国儿童早期食物过敏和呼吸道过敏症状、注意力缺陷/多动症代表性研究

食物过敏和呼吸道过敏以及注意力缺陷/多动症(ADHD)在儿童中的相关关系的研究很少。最近,有研究人员鉴定了是否早期食物过敏和呼吸道过敏症状与ADHD在中国学龄儿童中的流行度有相关性。研究人员的代表性研究在2005年11月和12月之间进行,使用的是聚类-分层分析方法,研究对象来自中国的9个城市的学龄儿童。研究发现,过敏性鼻炎(20.4%)和哮喘(11.6%)在食物过敏组中的流行度均比在非食物过敏组(

2017精神大会主题演讲:你吃什么会影响你的感受

在美国新奥尔良市一个精神病学大会上,杜兰大学的医学博士Timothy S. Harlan讨论了营养在神经认知和心理健康方面的重要性。

AmJ Epidemiol:孕妇服用扑热息痛增加孩子患多动症、自闭症风险

以色列研究人员发现,孕妇服用扑热息痛,孩子出生后患注意力缺陷多动障碍、即多动症的风险增加至多三成,患自闭症的风险增加至多两成。

新理论:睡眠紊乱是多动症产生的原因

大约75%的儿童和成人注意缺陷多动障碍(ADHD)患者有睡眠问题,一直以来,ADHD和睡眠被认为是独立的两个方面。最近在一项综合研究中,科学家提出了一种新理论,认为大部分多动症实际上可能与缺乏正常昼夜节律睡眠有关。

Radiology:小孩多动症在MR上会有什么改变呢?

本研究旨在验证注意力不良多动症(ADHD)诊断及分型相关的脑放射组学特征,基于以上特征建立诊断ADHD及其分型的分类,并将结果发表在Radiology上。

Baidu
map
Baidu
map
Baidu
map